close

Enter

Log in using OpenID

Actinic Keratosis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Global Actinic Keratosis Treatment Market is calculated to value over USD 8.5 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029 Actinic keratosis is mainly observed in regions with a thin ozone layer as it is caused by prolonged e
Actinic Keratosis Treatment Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2029
Global Actinic Keratosis Treatment Market is calculated to value over USD 8.5 Billion
by 2029 end and register a CAGR of over 4% from 2019 to 2029
Actinic keratosis is mainly observed in regions with a thin ozone layer as it is caused
by prolonged exposure to dangerous UV rays which can result into squamous cell
carcinoma. It is mainly observed in men and around 20% of patients with injuries
from actinic keratosis create dangerous squamous cell carcinoma.
Market Growth Influencers:
There has been a rise in the number of actinic keratosis across the world and drug
regulating authorities have taken initiatives for providing field-directed treatment for
such cases which has boosted the market to grow globally. Furthermore, minimally
invasive therapeutic methods are being recognised widely across the world which is
driving the market further. Added important driving factor for the market growth is
the rising geriatric population who are more prone to develop actinic keratosis.
Request a Sample Report @https://www.futurewiseresearch.com/requestsample.aspx?id=250&page=requestsample
Insights on Global Actinic Keratosis Treatment Market:
1. By Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Actinic keratosis is prominently observed in the North American region due to the
presence of a thin ozone layer in the region and hence this region dominates the
global market. Additionally, patients highly prefer minimally invasive treatments and
they are capable of spending on such treatments which drives the market further.
Furthermore, the majority of the vendors providing minimally invasive treatments
are present in the U.S which strengthens their market position thus resulting in their
domination over the market.
Asia Pacific region has huge potential for substantial market growth. Australia in
particular has a prominent occurrence of actinic keratosis and it is found in around
40%-50% of the adult population. Creating awareness regarding actinic keratosis and
implementation of efficient social insurance are some of the factors that will help
this market space to strengthen its position.
2.
•
o
o
o
o
By Treatment Type
Topical Treatment
5-Fluorouracil Cream
Diclofenac Gel
Imiquimod Cream
Ingenol Mebutane Gel
• Photodynamic Therapy (PDT)
• Procedural Modality
o Chemical Peels
o Cryotherapy
Topical medications dominated this market in 2018 due to its profound market
penetration and easy availability. Additionally, this treatment has a low risk of
creating scars on a patient’s body which drives this segment further.
Photodynamic treatment is the fastest growing segment due to a reduction in the
number of treatment sessions and a rising interest in non-obtrusive surgeries.
3. By End User
• Hospitals
• Private Dermatology Clinics
• Laser Therapy Centres
• Cancer Treatment Centres
• Spas & Rejuvenation Centres
• Home Care
Hospital segment dominates this market due to the ease of accessibility and
availability of actinic keratosis treatments to patients. The key driving factor for this
segment to grow is the rise in healthcare services.
Homecare is expected to witness rapid market growth during the forecast period.
This is due to a rise in the awareness of consumers and the plethora of self-care
treatment options that are available and are affordable to everyone.
4. By Disease Type
• Clinical Actinic Keratosis
• Sub-Clinical Keratosis
Prominent Players:
• Galderma
• DUSA Pharmaceuticals
• Athenex Inc.
• Chongqing Jingdong Junzhou Pharmaceuticals Co. Ltd
• Bausch Health Companies Inc.
• LEO Pharma A/S
• Sun Pharmaceutical Industries Ltd.
• Novartis International AG
• Hill Dermaceuticals
Athenex Inc. and Chongqing Jingdong Junzhou Pharmaceuticals Co. Ltd announced a
partnership in January 2019 for the development of an ointment KX2-391 for treating
actinic keratosis in China. This partnership will be helpful for both the parties to
strengthen their market position considering how big and important the Chinese
market region is.
Purchase a Copy of this Premium Research Report At:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=250&license=single
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global actinic keratosis treatment
market by region, by treatment type, by end user, by disease type
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America,
Europe, Asia Pacific, Middle East & Africa and Latin America
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
7
File Size
16 KB
Tags
treatment, healthcare, health
1/--pages
Report inappropriate content